Government Funding Accelerates Venture Interest In China
This article was originally published in PharmAsia News
Executive Summary
HONG KONG - The growth in available government funding for pharmaceutical companies in China is creating a snowball of investment from domestic and multinational pharma companies more willing to overcome intellectual property concerns